We are live on ! Find out more
APTO

Aptose Biosciences, Inc.

Delisted

APTO was delisted on the 1st of April, 2025.

4 hedge funds and large institutions have $35.8K invested in Aptose Biosciences, Inc. in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 34 (+1)

27% more capital invested

Capital invested by funds: $28.1K → $35.8K (+$7.68K)

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
FFA
Farther Finance Advisors
California
+$15

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
DS
1
DRW Securities
Illinois
$29.2K
GG
2
Gleason Group
Kentucky
$6.5K
FFA
3
Farther Finance Advisors
California
$15 +$15 +10 New
CSC
4
Caldwell Sutter Capital
California
$3

APTO Hedge Fund Activity: Q4 2025 in Review

4 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q4 2025, worth a combined $35.8K — up 27% from $28.1K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new APTO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Farther Finance Advisors, opening a new position worth an estimated $15.

  • 4 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q4 2025, up from 3 in Q3 2025.
  • Funds reported $35.8K of Aptose Biosciences, Inc. stock for Q4 2025, up 27% quarter-over-quarter.
  • 1 fund opened new Aptose Biosciences, Inc. positions in Q4 2025 and 0 closed out, a net change of +1 holder.
  • The largest Aptose Biosciences, Inc. buyer in Q4 2025 was Farther Finance Advisors, an estimated $15 added.

Based on aggregated 13F filings for Q4 2025.